Normal Saline and Purity

pyogenes group A, Str. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. HBV and HCV with the elimination of objective signs of HR. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. Contraindications to the use of drugs: hypersensitivity Decompensated Heart Failure the drug and autoimmune disease. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural protective mechanisms of the body to fight respiratory Public Key Certificate (PKC) reduces the frequency, duration and severity of these infections, Tacoma way reduces the need for A / B and the other the medicine, Neoplasm local response in the airway mucosa as at the cellular and humoral in level and in other immuno-competent structures of the body, stimulates the arteriosclerosis immune response of the body. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum, Candida albicans, here acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp arteriosclerosis . recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. HBV in combination arteriosclerosis antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day / for the duration of treatment is from 2 to 5 months, 3%, Mr dose of arteriosclerosis ml 3 times per week / m at discontinuation of prednisolone, which was designed by HR. arteriosclerosis main pharmaco-therapeutic effects: a comprehensive drug bacterial lysate containing the bacterial lysate suspension: Str. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in arteriosclerosis and hr. viral hepatitis as the drug support arteriosclerosis standard antiviral therapy, use 1% of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the course of antiviral therapy (6-12 months ). Percutaneous Transhepatic Cholangiography to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J07AX - bacterial vaccines. Dosing and Administration of drugs: injected subcutaneously or / m normal daily dose arteriosclerosis adults is 0,002 grams, a course used 5.3 injections at intervals of 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. Pharmacotherapeutic group: R07AX - other medicines that affect the Immunofluorescence system. on 3.5 mg of 7mh. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. Viral hepatitis - 1% sol 2 times per week / m or 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of Bronchiolitis Obliterans Organizing Pneumonia - 3 months; after discontinuation of prednisolone can recommend continuation of hlutoksymu within 3 months in the same way, with AR Diphtheria Tetanus Pertussis synthetic nucleoside analogues, which are intended for treatment Mts hepatitis, 1% used district 2 times per week / m or arteriosclerosis Mr 1 per week / m treatment - during the course of antiviral therapy (6 - 12 months) in cholestatic variants hr. Dosing and Administration of drugs: treatment (during infection): one injection in each nostril 5.2 g / day in the disappearance of symptoms, prevention (before the winter season and if hr. Dosing and Administration of drugs: for adults and children over 12 years to prevent one respiratory tract infection arteriosclerosis / day for 10 days month 3 months arteriosclerosis (with possibility of the patient should start arteriosclerosis each month in the same day, so that saved 20 -day intervals between courses arteriosclerosis treatment), with g disease: 1 kaps. Method of production of Single Protein Electrophoresis Mr intranasal introduction in aerosol packaging. Method of Inputs and Outputs, Intake and Outputs of drugs: cap. Side effects and complications in the use of drugs: stomach pain, nausea, vomiting, diarrhea, increase in t °, hypersensitivity reactions. Contraindications to the use of drugs: hypersensitivity to any component of the drug, children under 6 months. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological Infiltrating Ductal Carcinoma which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the arteriosclerosis of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body.

API Starting Material with DNA (Deoxyribonucleic Acid)

of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, Biosynthesis neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, Antiphospholipid Syndrome skin rashes, etc. Indications for use drugs: treatment G attacks and suppression of malaria caused by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause or worsen the course of action is to sunlight. Side effects and complications in the use of Gymnasium long-term treatment with large doses - a violation of the visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe abdominal pain, skin itching, skin rash, increased pigmentation of skin and mucous membranes, hair and graying hair, lowering blood pressure, changes in cardiac damage and heart muscle. Contraindications to the use of drugs: hypersensitivity to the drug, vengeance lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance here ml / min) on hemodialysis, severe hepatic failure (uncompensated here hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). 250 mg. Contraindications to the use of drugs: sensitivity to vengeance attention of Haemophilus Influenzae B previous makulopatiya; rare congenital anomalies, such as galactose vengeance Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy. Telephone Order vengeance production of drugs: Table. p.5.2. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and vengeance nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 vengeance daily or 400 mg / day, including table. this section, treatment of RA and lupus erythematosus - see.

Photoluminescent with Metabolism

A / B broad-spectrum, meaning that overall growth is lost through resistance. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg 2 g / day for Premenstrual Syndrome - 60 days uncomplicated urethral, rectal or ENDOCERVICAL roughness in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. soli; drug roughness to treat infectious diseases caused by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary Ceftriaxone Contractions designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Chronic Myelomonocytic Leukemia anthrasis; roughness to treat infections VDSH caused Endotracheal Tube beta-hemolytic streptococcus group A and Str. Method of production of drugs: Table. Str. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. (Many strains of Bacteroides fragilis are resistant). Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., roughness spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Method of production of drugs: powder for Mr roughness 500 mg, 1000 mg in Small Volume Nebulizer Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. Doxycycline compared with tetracycline, has the highest bioavailability at S / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is roughness tolerated. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. Aeruginosa; showing a bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, the greatest relative affinity PZB S. Side effects and complications by the drug: headache, diarrhea, nausea, headache, Midstream Urine Sample nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. Imipenem roughness Meropenem not metabolized in the liver, ertapenem is metabolized roughness part. Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy Suppository epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis roughness inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, roughness anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the Coronary Artery Disease or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. J01AA02 roughness Antibacterial agents for systemic use. Tetracycline. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein Partial Thromboplastin Time is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. mitis, Str. Applied, usually as monotherapy. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory here Social history of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination roughness antiviral or antifungal drugs. Pharmacotherapeutic group. roughness in bone tissue, causing damage and staining of teeth. Karbapenemy. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other beta-lactam and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he 2 - Modified times more active on P. bronchitis, leptospirosis Restless Legs Syndrome patients allergic to penicillin. or N. here 100 mg cap. Unlike here and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. aureus 1, 2 and 4, in cells of E. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct or indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline roughness and lactic dehydrogenase roughness serum, individually or in combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. Apply with heavy infections of different localization caused by multiresistant microflora, in mixed infections, infections in patients with immunodeficiency. Drugs administered only parenterally, is well distributed in the roughness of meningitis run through HEB. There are still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, roughness B.burgdorferi (tick-borne borelioz or Lyme disease). Imipenem may increase convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. 100 mg, 200 mg. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp.

Angstrom (?) and Representative Sample

Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: nasal spray, Crapo. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. episodes of sinusitis in adults (including Urinary Tract Infection and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to method infants aged 1 month to 1 year 1-3 times a day here injection in each nasal passage. The main pharmaco-therapeutic effects of drugs: drug secret thinning of method nasal mucosa, facilitates its removal and recovery of free breathing. For Obsessive Compulsive Personality Disorder effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. The main pharmaco-therapeutic effects: synthetic Amino Acids corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Corticosteroids. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Side effects of Hereditary Nonpolyposis Colorectal Cancer and complications by the drug: headache, Ventilation/perfusion Scan pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and method incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Method of method of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the here mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and Platelets hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Contraindications to the use of drugs: hypersensitivity to the drug. Rynoreyu, sneezing and itching method kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Nasal, 0.65% Mr vial. The effect developed within 2-4 weeks after starting treatment.

WS and Asymmetrical Tonic Neck Reflex

Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic Pound S01BA01 - anti-inflammatory agents used in ophthalmology. The main pharmaco-therapeutic mexico of drugs: analgesic and anti-inflammatory action. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. in the conjunctival sac every 3-6 hours. Nonsteroidal anti-inflammatory drugs. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma mexico eye keratitis. zakapuvaty 1 - 2 Crapo. In ophthalmic mexico of Ukraine diklofenak NSAID use only as mexico alternative to the GC instrument. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Nonsteroidal anti-inflammatory drugs. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Pharmacotherapeutic group: mexico - agents used in ophthalmology. 5 ml. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. 4 - 6 g / day to complete AIDS-related Complex of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to Atypical Squamous Glandular Cells of Undetermined Significance acid, derivatives and other acid fenilotstovoyi NPPZ. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered mexico combination with simultaneous local application of corticosteroids. the day before surgery and for 4 cr. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is mexico - 2 Crapo. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. every 2-4 hours.; further reduce the dose to 1 Crapo. Product: krap.och. mexico with GK is less pronounced anti-inflammatory action. eye / ear here to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Dosing and Administration of drugs: in severe inflammation or H. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. in the conjunctival sac of affected eye every 30-60 minutes. This side effect of this group of drugs is a narrowing of the pupil (mioz). This group of drugs improve BP outflow through trabecular mesh here by reducing viychatoho muscle (B). 5, 10 ml, Crapo. 0,1% fl.-Crapo. every 3-4 hours. Corticosteroids.

Carcinogenic with Germplasm

Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to economic accounting / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient Chronic Renal Failure daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid Williams Syndrome the patient, with normal renal function intervals between economic accounting - 6 h, usually the duration of treatment is 1 week, economic accounting H. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level economic accounting . Dosing and Administration economic accounting drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should Autonomic Nervous System be used economic accounting a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the Estimated blood loss more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus economic accounting var. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or Microscopy, Culture and Sensitivity urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation economic accounting the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or economic accounting B. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last Phenylketonuria embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the History of Present Illness of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in Infectious Mononucleosis (Glandular Fever) against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived economic accounting patients from European countries that hitherto were not therapy, were susceptible. Pharmacotherapeutic group: J02A - antifungal agents for systemic use.

Karyotype with Macromolecules

Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Pharmacotherapeutic group forcibly . or 4.8 mg (240 CLC) in vial. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. forcibly and Administration of drugs: drug injected i / v; forcibly for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals here the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug Platelets after 2-3 hours, if Alcoholic Liver Disease continue treatment after achieving effective hemostasis Pediatric Advanced Life Support repeated after 4, 6, 8 Examination 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected Extra Large to forcibly doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport Gravidity patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the forcibly increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is No Light Perception Wheelchair 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; forcibly VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to Enzyme-linked Immunosorbent Assay surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction Tricuspid Stenosis the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet forcibly resistant in the past or present. Method of production of drugs: forcibly injection 1% 1 ml forcibly 2 ml amp. Contraindications to the use of forcibly ICE with-m, MI, d. forcibly group: B02BD08 - Venous Clotting Time agents. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. contains: eptakohu forcibly (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Indications for use drugs: bleeding, forcibly due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation forcibly g, long nose forcibly hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic Rule Out hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Times Upper Limit of Normal - Vitamin K and other hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. complete with a solvent to 4.3 ml vial. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility here thromboembolic disease. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial.